Register Now

3rd Swiss Autoimmune Liver Disease Meeting 2020

The conference is a two-day event with invited speakers, and posters. The event brings together faculty, young investigators, basic scientists and clinicians for an opportunity to connect and exchange ideas. At the end of each talk, some time for discussion and questions has been allocated to enhance the interaction between the faculty and the audience. 
We strongly encourage all actors in the field to submit an abstract describing new, previously, or concurrently published research. Posters will be viewed during dedicated timing in the scientific programme and during the allocated breaks. 
Palazzo dei Congressi

Scientific Programme

New Program - November 2020

EpatoCentro 3rd LiverDisease Meeting 2020
Language

All abstracts must be submitted in English

Length

Title: 50 – 250 characters
Content: unlimited, but the organizers recommend a maximum of 2,500 characters

General

Abstracts that have already been presented at another congress may be submitted
Avoid complex mathematical formulas and key words 
Corrections can be made up to December 14, 2019 (submission deadline)

Confirmation of submission

An automatic confirmation e-mail will be sent through our system.
For more information, please contact: swissaildmeeting@epatocentro.ch 

Notification

All abstract submitters will be notified by January 4, 2020
All abstracts that have been accepted for a poster presentation(s) require that at least one author attends the conference to present the work, and answer questions.
Full instructions concerning the preparation and presentation will be provided in the acceptance e-mail.

Submission deadline

December 14, 2019

Registration

All authors with an accepted abstract are requested to register to the conference.  
Early registration fees are available up to January 13, 2020

Copyrights

By submitting an abstract to this event you agree with the following statement:  
"I hereby assign to the Fondazione Epatocetro the copyrights to the abstract submitted to the 3rd Swiss Autoimmune Liver Disease meeting (government authors not electing to transfer agree to assign an exclusive publishing and distribution license) and any supplemental tables, illustrations or other information submitted therewith that are intended for publication as part of the abstract in all forms and media (whether now known or hereafter developed), throughout the world, in all languages, for the full term of copyright, effective when and if the article is accepted for publication. This transfer includes the right to provide the abstract in electronic and online forms and systems."